Jeff Sheckter
Président chez Metabolomic Technologies, Inc.
Profil
Jeff Sheckter has held positions as Chairman at Metabolomic Technologies, Inc. and Executive Vice President at Triple Five Group Ltd.
Postes actifs de Jeff Sheckter
| Sociétés | Poste | Début |
|---|---|---|
Triple Five Group Ltd.
 Triple Five Group Ltd. Real Estate DevelopmentFinance Triple Five Group Ltd. develops commercial real estate properties. It develops and manages world-scale ventures such as shopping centers, tourism projects, office buildings, urban entertainment destinations, recreation and amusement parks, hospitality projects, and residential developments. The company was founded by Jacob Ghermezian in 1965 and is headquartered in Edmonton, Canada. | Corporate Officer/Principal | - |
Metabolomic Technologies, Inc.
 Metabolomic Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Metabolomic Technologies, Inc. is a Canadian company that specializes in developing in vitro diagnostics using metabolomics. Metabolomic Technologies was founded by Haili Wang and Richard Fedorak and is based in Edmonton, CA. The company's lead product, PolypDX™, is a urine-based screening test for colorectal cancer. The company utilizes a unique metabolomics platform to identify distinct metabolic fingerprints and develop accurate diagnostic tests. | Président | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Triple Five Group Ltd.
Triple Five Group Ltd. Real Estate DevelopmentFinance Triple Five Group Ltd. develops commercial real estate properties. It develops and manages world-scale ventures such as shopping centers, tourism projects, office buildings, urban entertainment destinations, recreation and amusement parks, hospitality projects, and residential developments. The company was founded by Jacob Ghermezian in 1965 and is headquartered in Edmonton, Canada. | Finance |
Metabolomic Technologies, Inc.
Metabolomic Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Metabolomic Technologies, Inc. is a Canadian company that specializes in developing in vitro diagnostics using metabolomics. Metabolomic Technologies was founded by Haili Wang and Richard Fedorak and is based in Edmonton, CA. The company's lead product, PolypDX™, is a urine-based screening test for colorectal cancer. The company utilizes a unique metabolomics platform to identify distinct metabolic fingerprints and develop accurate diagnostic tests. | Commercial Services |
